Form 4 for SER Serina Therapeutics, Inc.
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001493152-24-022200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-31 | 2024-05-29+ | SER | Bailey Gregory | Dir | P - Purchase | $9.50 | +6,378 | 15.0K | +74% | +$60.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | P | A | 5,205 | $9.50 | 20,206 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-29 | P | A | 1,173 | $9.50 | 15,001 | D | — | — |